Ceragon Networks Ltd (NASDAQ: CRNT) shares are trading higher after it disclosed a deal with a global integrator for around $150 million to support a network modernization project for a
West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.03 per share which missed the analyst consensus estimate of $2.12 by 4.25 percent. This is a 1.46 percent decrease over earnings of $2.06 per share